leadf
logo-loader
viewWeedMD Inc

WeedMD posts C$5.9M in 2Q revenue as it sharpens focus on higher margin, direct-to-consumer model

Total cannabis sold came in at nearly 977,000 grams at an average selling price of C$4.96 per gram and a cultivation cost of C$0.55 per gram

WeedMD Inc -
For the six-month period to end June 30, WeedMD recorded net revenue of $18 million, spurred by its acquisition of Starseed Medicinal Inc in December 2019

WeedMD Inc (CVE:WMD) (OTCQX:WDDMF) (FRA:4WE) reported its fiscal 2Q results that saw it generate C$5.9 million over the quarter ended June 30, 2020, driven by its new direct-to-consumer model in the adult-use market.

The cannabis company is sharpening its focus on higher-margin consumer-directed revenue, which contributed $2.4 million to overall revenue for the quarter.

Total cannabis sold came in at nearly 977,000 grams at an average selling price of C$4.96 per gram and a cultivation cost of C$0.55 per gram, as compared to the C$3.76 per gram at C$0.96 cultivation cost it sold for during the same period a year ago.

READ: WeedMD closes deal for C$30M credit facility with LiUNA Pension Fund

For the six-month period to end June 30, WeedMD recorded net revenue of $18 million, spurred by its acquisition of Starseed Medicinal Inc in December 2019.

“During the second quarter, we advanced our integration with Starseed to drive direct-to-consumer revenue and made significant operational progress in ramping up production,” CEO Angelo Tsebelis told shareholders in a statement.

“Our unique medical service platform and growing brand recognition for our Color Cannabis adult-use products contributed to our revenue for the quarter.”

The Toronto-based company also entered into multiple new strategic partnerships and new consumer categories during the quarter, with expanded products manufactured from in-house biomass at its extraction facility.

Tsebelis added that the group anticipates an “impressive” harvest from its outdoor platform in the coming weeks.

Credit facility increases liquidity

Earlier this week, WeedMD closed a C$30 million credit facility from its strategic investor LiUNA Pension Fund of Eastern and Central Canada (LPF), strengthening its liquidity and allowing the firm to boost brand awareness and distribution channels.

“The continued support and $30 million in non-dilutive financing we received from our partner and strategic investor LPF will provide us with increased liquidity to support our future sales growth,” Tsebelis added.

WeedMD reported an adjusted EBITDA loss of C$5 million during the quarter as a result of an inventory write-off of around $1.3 million, substantial expenses incurred related to increased production, selling and general and administrative expenses, prior to optimization initiatives underway in the second half of 2020, it told investors.

The company ended the period with C$5.7 million in cash and equivalents.

Contact Angela at [email protected]

Follow her on Twitter @AHarmantas

Quick facts: WeedMD Inc

Price: 0.26 CAD

TSX-V:WMD
Market: TSX-V
Market Cap: $54.67 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of WeedMD Inc named herein, including the promotion by the Company of WeedMD Inc in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Buds & Duds: Cannabis stocks off to slow start to the holidays; WeedMD rises...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, fell 1.8% to settle at 115.4 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF lost 2.1% at C$8.99, while the OTCQX Cannabis dropped 2.3% at 444.7 points. Buds today are WeedMD Inc...

on 12/02/2019

2 min read